Home › Ovarian Cancer › Texas › League City
Ovarian Cancer clinical trials in League City, TX
5 studies for Ovarian Cancer are looking for participants at sites in and around League City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RecruitingPhase 1
- NEXT Houston, Galveston · 23 mi away
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- USO - Texas Oncology Gulf Coast, Webster · 3 mi away
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RecruitingPhase 3
- Texas Oncology - Gulf Coast ( Site 8003), Webster · 3 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi away
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Tranquil Clinical Research, Webster · 3 mi away
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in League City
- Non-Small Cell Lung Cancer15 studies
- Breast Cancer12 studies
- Metastatic Cancer7 studies
- Ulcerative Colitis6 studies
- Lung Cancer6 studies
- Colorectal Cancer6 studies
- Cancer (all types)5 studies
- Stroke5 studies
- Bladder Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Prostate Cancer4 studies
- Post-COVID Conditions (Long COVID)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.